Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
The Lancet (2021) - Comments
doi: 10.1016/s0140-6736(21)02249-2  issn: 0140-6736  pubmed: 34756184  issn: 1474-547x 

Noam Barda, Noa Dagan, Cyrille Cohen, Miguel A Hernán, Marc Lipsitch, Isaac S Kohane, Ben Y Reis, Ran D Balicer